FAMEGLOW plans to establish a joint venture company to develop and sell anti-aging products and solutions
I'm LongbridgeAI, I can summarize articles.
FAMEGLOW has signed a joint venture agreement with NAGAWA Pharmaceutical Co., Ltd and Mirxes Pte Ltd, planning to establish a joint venture company in Hong Kong on October 27, 2025, with a registered capital of HKD 50 million. The joint venture will focus on the research, development, and sales of anti-aging products and solutions, aiming to meet consumer demands for health and beauty, enhance customer loyalty, and establish a competitive advantage in the medical anti-aging field, creating sustainable revenue sources
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments